garcinol has been researched along with Angiogenesis, Pathologic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aggarwal, S; Das, SN | 1 |
Najafi, R; Pourjafar, M; Ranjbarnejad, T; Saidijam, M; Tafakh, MS; Talebzadeh, F | 1 |
2 other study(ies) available for garcinol and Angiogenesis, Pathologic
Article | Year |
---|---|
Garcinol inhibits tumour cell proliferation, angiogenesis, cell cycle progression and induces apoptosis via NF-κB inhibition in oral cancer.
Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Cycle; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Humans; Mouth Neoplasms; Neovascularization, Pathologic; NF-kappa B; Plant Extracts; Terpenes; Tumor Cells, Cultured | 2016 |
Garcinol exhibits anti-proliferative activities by targeting microsomal prostaglandin E synthase-1 in human colon cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Colonic Neoplasms; Dinoprostone; Gene Expression Regulation; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microsomes; Neovascularization, Pathologic; Prostaglandin-E Synthases; Receptors, CXCR4; Signal Transduction; Terpenes; Vascular Endothelial Growth Factor A | 2017 |